Existing research has revealed that fibroblasts can promote the tumor drug resistance of ccRCCs through the TDO/Kyn/AhR signaling pathway (18), and they are positively correlated with tumor initiation and adverse prognosis (19). This evidence concerns the gene AHR and neoplasm.